Opko Health, Inc. (NASDAQ:OPK) shares are trading higher Thursday after the company announced a $100 million share repurchase program. Opko said it expects to fund the repurchase program from existing ...

OPKO Health's stock is flying high but volatile. The Quant Rating was recently upgraded to Buy, but has been mostly rated Hold or Sell. The company's focus on niche markets and acquisitions poses ...

OPKO Health, Inc. OPK is well-poised for growth in the coming quarters, supported by the potential of RAYALDEE. The optimism surrounding the stock is backed by RAYALDEE’s performance and strategic ...

We recently compiled a list of the 10 Best Stocks Under $3 to Buy Now. In this article, we are going to take a look at where OPKO Health, Inc. (NASDAQ:OPK) stands against the other stocks under $3.

OPKO Health stock has bounced back since February but remains down over 11% since last year. OPK stock's rally in recent months has been supported by strong buying volume and positive earnings ...

Entera Bio Ltd. ENTX and OPKO Health, Inc. OPK recently announced positive topline pharmacokinetic/pharmacodynamic (PK/PD) results from their ongoing collaborative ...

OPKO Health (OPK) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to earnings of $0.03 per share a year ago. These ...

OPKO Health, Inc. OPK is a diversified healthcare company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing ...

The pharmaceutical and diagnostics specialist ran into some SEC-related controversy in 2018; now, it's a major player in the fight against COVID-19. To sum up, it's not a bad idea to pay attention to ...